Catalyst Pharmaceuticals Inc (STU:CN2)
€ 20.71 0.15 (0.73%) Market Cap: 2.46 Bil Enterprise Value: 2.04 Bil PE Ratio: 18.19 PB Ratio: 3.87 GF Score: 88/100

Catalyst Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Sep 19, 2022 / 01:00PM GMT
Release Date Price: €13.01 (-2.46%)
Operator

Good morning, and welcome to the 2022 Annual Meeting of Stockholders of Catalyst Pharmaceuticals, Inc.

Before we get started, I'd like to go over a few items so you know how to participate in today's meeting. You've joined the meeting using your computer speaker system by default. If you wish them to listen into the meeting by telephone, you may use the phone number included in the proxy statement for the meeting, which is also set forth on the website for this annual meeting.

During the meeting, you will have the opportunity to submit questions to today's presenters by typing in the Ask a Question box on the website for this annual meeting. Today's meeting is being recorded. I would now like to introduce Patrick J. McEnany, CEO of Catalyst Pharmaceuticals, who will preside over today's meeting. Thank you.

Patrick J. McEnany
Catalyst Pharmaceuticals, Inc. - Co-Founder, Chairman, President & CEO

Good morning, and welcome to the 2022 Annual Meeting of Stockholders of Catalyst Pharmaceuticals, Inc. I'm Patrick J. McEnany, the Chairman,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot